# Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

> **NCT01120002** · PHASE2 · UNKNOWN · sponsor: **Osaka City University** · enrollment: 50 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Tamibarotene
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01120002
- **Lead sponsor:** Osaka City University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120002, "Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01120002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*